Ethical Implications of Stem Cell Therapy in Diabetes Treatment
Diabetes, a chronic disease affecting millions worldwide, continues to challenge modern medicine. Despite significant advances in treatment, the quest for more effective and lasting solutions is ongoing. Among these potential breakthroughs, stem cell therapy stands out as a beacon of hope. However, as we delve into the realm of regenerating damaged tissues and creating new […]
UP421: Revolutionizing Diabetes Treatment Without Immunosuppression
Uppsala University Hospital and Sana Biotechnology recently announced a groundbreaking development in diabetes treatment. They have received authorization from the Swedish Medical Products Agency for a first-in-human clinical trial of UP421, a novel islet cell therapy for type 1 diabetes. This treatment, developed using Sana’s innovative hypoimmune (HIP) technology, aims to transplant functional islet cells […]
Revolutionary Type 1 Diabetes Cure: Melton’s Abarca Prize Triumph
Professor Douglas A. Melton has made a groundbreaking contribution to the medical field with his research focused on curing Type 1 diabetes. His innovative approach involves transplanting insulin-producing cells, particularly pancreatic beta cells. These cells are capable of measuring glucose levels and secreting the appropriate amount of insulin, which has led to a “functional cure” […]
Revolutionary Stem Cell Cure for Type 1 Diabetes?
The video below titled “Beta Cells From Stem Cells Nearing a Cure for Type 1 Diabetes” features Dr. Anne L. Peters discussing the results of clinical trials involving beta cells derived from stem cells in patients with type 1 diabetes. The trials were conducted by a company named Vertex, for which Dr. Peters serves on […]
Insulin Independence: Is This the Future for Type 1 Diabetes Patients?
The press release from the American Diabetes Association presents promising findings from an ongoing clinical trial of VX-880, a novel stem cell-derived islet cell therapy for individuals with type 1 diabetes (T1D). The study, presented at the 83rd Scientific Sessions of the American Diabetes Association, demonstrates the potential of this therapy as a future treatment […]
Could Stem Cell Therapy be the Answer to Your Autoimmune Disease? Let’s Explore
If you, or someone you love, is grappling with an autoimmune disease, it’s natural to explore every possible avenue to manage or potentially reverse its effects. This article aims to shed light on one of the emerging treatment options – stem cell therapy. Autoimmune diseases are conditions where the body’s own immune system mistakenly attacks […]
From Stem Cells to Insulin Producing ß-cells
In this round table video clip, Dr. Camillo Ricordi and Dr. Melena Bellin discuss the current strategies being studied for restoring glycemic control in Type 1 Diabetes with stem cells.
Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line
PHOENIX, Oct. 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, announced today that through predominantly internal and collaborative development, it has produced an allogenic Cell Line called AlloStem™, which includes a Master Cell Bank and a Drug Master File which shall […]
Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz® Product
PHOENIX, April 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced progress in developing a reproducible clinical grade product of ImmCelz®. Multiple clinical experiments were performed in which […]